Suppr超能文献

社会经济因素与食管癌手术时机及其预后的关系。

Socioeconomic factors in timing of esophagectomy and association with outcomes.

机构信息

Department of Surgery, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

出版信息

J Surg Oncol. 2021 Dec;124(7):1014-1021. doi: 10.1002/jso.26606. Epub 2021 Jul 12.

Abstract

BACKGROUND AND OBJECTIVES

Disparities in esophageal cancer are well-established. The standard treatment for locally advanced esophageal cancer is chemoradiation followed by surgery. We sought to evaluate the association between socioeconomic factors, time to surgery, and patient outcomes.

METHODS

All patients ≥18 years old diagnosed with T2/3/4 or node-positive esophageal cancer between 2004 and 2016 and who underwent chemoradiation and esophagectomy in the National Cancer Database were included. Multivariable regression was used to assess the association between socioeconomic variables and time to surgery (grouped into <56, 56-84, and 85-112 days).

RESULTS

A total of 12 157 patients were included. Five-year overall survival was 39%, 35%, and 35% for the three groups examined. Postoperative 30- and 90-day mortality was increased in both the 56-84 days to surgery group (odds ratio [OR]: 1.30 and 1.20, respectively) and the 85-112 days group (OR: 1.37 and 1.56, respectively) when compared to <56 days. Patients of a minority race, public insurance, or lower income were more likely to have a longer time to surgery.

CONCLUSION

Longer time to surgery is associated with increased postoperative mortality and is more common in patients with lower socioeconomic status. Further research exploring reasons for delays to esophagectomy among disadvantaged patients could help target interventions to reduce disparities.

摘要

背景与目的

食管癌存在明显的差异。局部晚期食管癌的标准治疗方法是放化疗后再进行手术。我们旨在评估社会经济因素、手术时间与患者预后之间的关系。

方法

本研究纳入了 2004 年至 2016 年间在国家癌症数据库中诊断为 T2/3/4 期或淋巴结阳性食管癌且接受放化疗和食管癌切除术的年龄≥18 岁的所有患者。采用多变量回归评估社会经济变量与手术时间(分为<56、56-84 和 85-112 天)之间的关系。

结果

共纳入 12157 例患者。三组患者的 5 年总生存率分别为 39%、35%和 35%。与<56 天相比,56-84 天和 85-112 天两组的术后 30 天和 90 天死亡率均升高(比值比[OR]:1.30 和 1.20,分别;OR:1.37 和 1.56,分别)。少数民族、公共保险或低收入患者更有可能手术时间较长。

结论

手术时间延长与术后死亡率增加相关,且在社会经济地位较低的患者中更为常见。进一步研究探索弱势患者接受食管癌切除术延迟的原因,可能有助于确定减少差异的干预措施。

相似文献

1
Socioeconomic factors in timing of esophagectomy and association with outcomes.
J Surg Oncol. 2021 Dec;124(7):1014-1021. doi: 10.1002/jso.26606. Epub 2021 Jul 12.
2
Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.
J Geriatr Oncol. 2018 Jan;9(1):40-46. doi: 10.1016/j.jgo.2017.08.010. Epub 2017 Sep 6.
5
Chemoradiotherapy before and after surgery for locally advanced esophageal cancer: a SEER-Medicare analysis.
Ann Surg Oncol. 2013 Nov;20(12):3999-4007. doi: 10.1245/s10434-013-3072-9. Epub 2013 Jun 26.
6
Outcome of delayed versus timely esophagectomy after chemoradiation for esophageal adenocarcinoma.
J Thorac Cardiovasc Surg. 2020 Jun;159(6):2555-2566. doi: 10.1016/j.jtcvs.2019.09.169. Epub 2019 Oct 22.
7
Esophageal Cancer Treatment Is Underutilized Among Elderly Patients in the USA.
J Gastrointest Surg. 2017 Jan;21(1):126-136. doi: 10.1007/s11605-016-3229-5. Epub 2016 Aug 15.
8
Disparities in survival after trimodality therapy for esophageal adenocarcinoma.
Dis Esophagus. 2018 Sep 1;31(9). doi: 10.1093/dote/doy020.
9
Treatment of clinical T2N0M0 esophageal cancer.
Ann Surg Oncol. 2014 Nov;21(12):3739-43. doi: 10.1245/s10434-014-3929-6. Epub 2014 Jul 22.
10
Long-term survival based on pathologic response to neoadjuvant therapy in esophageal cancer.
J Surg Res. 2017 Aug;216:65-72. doi: 10.1016/j.jss.2017.03.022. Epub 2017 Mar 31.

引用本文的文献

3
Early thoracic surgery consultation and location of therapy impact time to esophagectomy.
J Thorac Dis. 2024 Sep 30;16(9):5615-5623. doi: 10.21037/jtd-24-316. Epub 2024 Sep 21.
4
Comparing the prognosis of esophageal adenocarcinoma with bone and liver metastases: A competing risk analysis.
PLoS One. 2024 Sep 25;19(9):e0303842. doi: 10.1371/journal.pone.0303842. eCollection 2024.
5
An Association Between Comorbidities and Postsurgical Complications in Adults Who Underwent Esophagectomy.
Cureus. 2023 Mar 20;15(3):e36395. doi: 10.7759/cureus.36395. eCollection 2023 Mar.
6
Geographical Disparities in Esophageal Cancer Incidence and Mortality in the United States.
Healthcare (Basel). 2023 Feb 25;11(5):685. doi: 10.3390/healthcare11050685.

本文引用的文献

1
Outcome of delayed versus timely esophagectomy after chemoradiation for esophageal adenocarcinoma.
J Thorac Cardiovasc Surg. 2020 Jun;159(6):2555-2566. doi: 10.1016/j.jtcvs.2019.09.169. Epub 2019 Oct 22.
4
Does timing of esophagectomy following neoadjuvant chemoradiation affect outcomes? A meta-analysis.
Int J Surg. 2018 Nov;59:11-18. doi: 10.1016/j.ijsu.2018.09.013. Epub 2018 Sep 24.
5
Timing of esophagectomy after neoadjuvant chemoradiation treatment in squamous cell carcinoma.
Surgery. 2018 Sep;164(3):455-459. doi: 10.1016/j.surg.2018.04.026. Epub 2018 Jun 11.
6
Predictors of Failure to Rescue After Esophagectomy.
Ann Thorac Surg. 2018 Mar;105(3):871-878. doi: 10.1016/j.athoracsur.2017.10.022. Epub 2018 Feb 2.
7
Time interval between neoadjuvant chemoradiotherapy and surgery for oesophageal or junctional cancer: A nationwide study.
Eur J Cancer. 2018 Mar;91:76-85. doi: 10.1016/j.ejca.2017.12.009. Epub 2018 Jan 30.
8
Appropriate timing for surgery after neoadjuvant chemoradiation for esophageal cancer.
Dis Esophagus. 2017 Sep 1;30(9):1-8. doi: 10.1093/dote/dox062.
9
Surgical resection after neoadjuvant chemoradiation for oesophageal adenocarcinoma: what is the optimal timing?
Eur J Cardiothorac Surg. 2017 Sep 1;52(3):543-551. doi: 10.1093/ejcts/ezx132.
10
Barriers to Accessing Optimal Esophageal Cancer Care for Socioeconomically Disadvantaged Patients.
Ann Thorac Surg. 2017 Feb;103(2):416-421. doi: 10.1016/j.athoracsur.2016.08.085. Epub 2016 Nov 5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验